Fulcrum Therapeutics, Inc.   (NASDAQ:FULC)

8.51    $-0.13   -1.50%
Market open   Sunday, May 22 2022 12:27 PM

Fulcrum Therapeutics, Inc. Chart

FULC Stock Price Today

Fulcrum Therapeutics, Inc. (FULC) stock plummeted over -1.50% intraday to trade at $8.51 a share on NASDAQ. The stock opened with a gain of 1.16% at $8.74 and touched an intraday high of $8.78, rising 1.62% against the last close of $8.64. The stock went to a low of $8.12 during the session.

Stock Snapshot

8.64
Prev. Close
8.74
Open
317.76M
Market Cap
40.64M
Number of Shares
8.12
day Low
8.78
Day High
8.51
-
P/E ratio
11.62%
Free Float in %
-2.34
EPS (TTM)
4.65
Book Value per Share
5.22
Cash Flow per Share
430386
Volume

Fulcrum Therapeutics, Inc. Historical Data

DateOpenCloseDaily HighDaily LowVolume
2022-05-20$8.74$8.51$8.78$8.12430,400
2022-05-19$8.53$8.64$9.03$8.42482,200
2022-05-18$8.51$8.50$8.86$8.34466,900
2022-05-17$8.54$8.74$8.76$8.43630,500
2022-05-16$8.24$8.30$8.58$8.02525,900
2022-05-13$7.54$8.28$8.43$7.51751,200
2022-05-12$7.20$7.57$7.82$7.07774,400
2022-05-11$7.52$7.20$7.72$7.04909,600
2022-05-10$7.55$7.55$7.83$6.881,325,400
2022-05-09$8.68$7.66$9.29$7.341,324,300
2022-05-06$8.85$8.63$8.85$8.102,119,600

Contact Details

26 Landsdowne Street
Cambridge, MA 02139
United States
https://www.fulcrumtx.com
617 651 8851

About Company

Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy; and FTX-6058, an investigational oral fetal hemoglobin inducer for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia. The company is also discovering drug targets for the treatments of rare neuromuscular, muscular, central nervous system, and hematologic disorders, as well as cardiomyopathies and pulmonary diseases. Fulcrum Therapeutics, Inc. has research and discovery collaboration agreement with Acceleron Pharma Inc. to identify biological targets to modulate specific pathways associated with a targeted indication within the pulmonary disease space; and has a strategic collaboration and license agreement with MyoKardia, Inc. to discover, develop, and commercialize novel targeted therapies for the treatment of genetic cardiomyopathies. Fulcrum Therapeutics, Inc. was Incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

Frequently Asked Questions

What is the current Fulcrum Therapeutics, Inc. (FULC) stock price?

Fulcrum Therapeutics, Inc. (NASDAQ: FULC) stock price is $8.51 as of the last check on Sunday, May 22 2022. During the trading session, FULC stock reached the peak price of $8.78 while $8.12 was the lowest point it dropped to.

FULC's industry and sector of operation?

The NASDAQ listed FULC is part of Biotechnology industry that operates in the broader Healthcare sector. Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States.

Who are the executives of FULC?

Dr. Robert J. Gould
CEO, Pres & Director

Mr. Bryan E. Stuart
Chief Operating Officer

Dr. Danny Reinberg
Founder

Mr. Peter G. Thomson
VP of Fin. & Accounting


What is the FULC stock price today?

FULC stock is trading at $8.51 today, which is $-0.13 or -1.50% lower than its previous close of $8.64. FULC's current trading price is -74.29% lower than its 52-week high of $33.10 where as its distance from 52-week low of $6.85 is 24.23%.

How many employees does FULC have?

Number of FULC employees currently stands at 73. FULC operates from 26 Landsdowne Street
Cambridge, MA 02139
United States.

Link for FULC official website?


How do I contact FULC?

FULC could be contacted at 26 Landsdowne Street
Cambridge, MA 02139
United States, or at phone # 617 651 8851 and can also be accessed through its website: https://www.fulcrumtx.com

How many shares of FULC are traded daily?

FULC stock volume so far today is 430386 shares while in the previous session number of FULC shares traded was 430400. The average number of FULC shares traded daily for last 3 months was 750530.

How much did FULC change today?

The percentage change in FULC stock occurred in the recent session was -1.50% while the dollar amount for the price change in FULC stock was $-0.13.

What price range FULC stock been trading in?

In the recent session, the day high for FULC stock was $8.78 while the low for FULC stock touched on the day was $8.12.

What is the market cap of FULC currently?

The market value of FULC currently stands at $317.76M with its latest stock price at $8.51 and 40.64M of its shares outstanding.